Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/10205
Title: Testicular infection in brucelosis: Report of 34 cases
Authors: Mile Bosilkovski 
Viktor Kamiloski 
Silvana Miskova
Danco Balalovski
Vesna Kotevska 
Mile Petrovski 
Keywords: brucellosis
epididymitis
orchitis
relapse
treatment
Issue Date: Feb-2018
Publisher: Elsevier
Journal: Journal of Microbiology, Immunology and Infection
Abstract: Background/Purpose To present clinical and laboratory features, treatment options, and outcome in patients with brucellar testicular infection and to compare them with analogous in brucellar patients without testicular involvement. Methods Thirty four brucellar patients with testicular infection treated in two general hospitals in the Republic of Macedonia, during the period 1998–2009, were retrospectively analyzed. Their clinical and laboratory characteristics were compared with analogous in 364 male brucellar patients without testicular infection, who were treated at the same hospitals during the same time period. Results Brucellar testicular infection was evident in 34 (8.5%) out of 398 male patients with brucellosis. The median age of the patients was 46.5 years. In all patients testicular involvement was presented as an acute form with a median duration of 5 days (range, 2–14 days) prior to diagnosis. Twenty-three of the patients had at least one other simultaneous focal infection. After starting with the treatment testicular infection lasted a median 10 days, range 7–21 days. Brucellar patients with testicular infection when compared with other brucellar patients more frequently manifested fever (97% vs. 61%), concomitant spondylitis (32% vs. 16%), and urinary system involvement (12% vs. 2%). Also, the relapse rate in patients with testicular involvement was significantly higher (24% vs. 9%). Conclusion In endemic regions brucellosis should be taken into consideration in any patient with testicular infection. Brucellar testicular involvement is usually characterized with a severe acute clinical presentation and a high percentage of relapses which entails the need of timely recognition and proper treatment duration of at least 60 days.
URI: http://hdl.handle.net/20.500.12188/10205
DOI: https://doi.org/10.1016/j.jmii.2016.02.004
Appears in Collections:Faculty of Medicine: Journal Articles

Show full item record

Page view(s)

52
checked on May 11, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.